CBRE Group
CBRE
$146.81
-1.77%
CBRE Group is the world's largest commercial real estate services and investment firm, providing leasing, property management, project management, and capital markets advisory to owners, occupants, and investors globally. As a market leader with over 155,000 employees and $155 billion in assets under management, CBRE dominates the real estate services industry through its scale and integrated platform. The current investor narrative centers on the company's ability to sustain revenue growth amid a challenging commercial real estate cycle, with attention on margin expansion from cost efficiencies and the potential for market share gains as smaller competitors struggle. Recent focus has been on CBRE's resilient advisory services segment and its investment management arm, which continue to drive performance despite headwinds in transaction volumes.…
CBRE
CBRE Group
$146.81
Investment Opinion: Should I buy CBRE Today?
Rating: Buy. CBRE offers a compelling risk/reward with accelerating revenue growth, expanding margins, and 26.1% upside to the average analyst target of $175.92. The forward P/E of 15.71x is reasonable given expected EPS growth to $13.35, and the PEG ratio of 1.82x suggests a fair valuation relative to growth.
Supporting evidence: Revenue grew 18.15% YoY to $10.527B, operating margin improved to 4.85% from 3.10%, net income rose to $318M from $163M, and free cash flow stands at $897M TTM. The consensus analyst rating is Buy with a mean target of $175.92, implying significant upside. The EV/EBITDA of 21.71x is above the sector median, but the P/S of 1.18x is low, suggesting the market is not fully pricing in revenue growth.
Risks & Conditions: The biggest risks are a slowdown in commercial real estate activity, failure to sustain margin expansion, and multiple compression from the high trailing P/E. This Buy rating would be downgraded to Hold if revenue growth decelerates below 10% or if margins contract. It would be upgraded if the stock breaks above $174.27 (52-week high) or if forward P/E compresses below 12x. Overall, CBRE appears fairly valued on forward earnings but overvalued on trailing earnings; the key is execution on growth.
Sign up to view all
CBRE 12-Month Price Forecast
CBRE's growth trajectory and margin improvement provide a strong fundamental backdrop, and the forward valuation is reasonable. The main risk is the high trailing P/E and cyclical exposure, but the base case of continued recovery and earnings growth supports the bullish stance. If revenue growth sustains above 15% and margins keep expanding, the stock could re-rate higher. However, any macro deterioration would quickly shift the outlook to neutral. The medium confidence reflects the uncertainty in the commercial real estate cycle.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $180.42 and implied upside of +22.9% versus the current price.
Average Target
$180.42
0 analysts
Implied Upside
+22.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$144 - $200
Analyst target range
CBRE is covered by 12 analysts, with a consensus recommendation of 'Buy' (mean recommendation 1.54 on a 1-5 scale where 1 is Strong Buy). The average target price is $175.92, implying approximately +26.1% upside from the current price of $139.46. The distribution leans bullish, with no sell ratings and recent upgrades (e.g., UBS upgraded from Neutral to Buy in February 2026). The target range spans from a low of $138.00 to a high of $200.00. The high target of $200 assumes continued revenue growth, margin expansion, and potential multiple expansion as the market recognizes CBRE's earnings power. The low target of $138, just below the current price, suggests some analysts see limited upside and price in risks such as a slowdown in commercial real estate activity or margin compression. The wide spread between low and high ($62) indicates significant uncertainty about the pace of recovery and earnings trajectory. Recent ratings from Evercore ISI, Barclays, and KBW have all maintained positive stances (Outperform/Overweight), reinforcing the bullish consensus. The strong buy consensus and substantial upside to the average target suggest analysts are confident in CBRE's growth story, but the wide range highlights the need for careful monitoring of execution.
Bulls vs Bears: CBRE Investment Factors
CBRE presents a compelling bull case driven by accelerating revenue growth (18.15% YoY), expanding margins (operating margin up 175 bps), and a strong analyst consensus with 26.1% upside to the average target. However, the bear case highlights a stretched trailing P/E of 41.44x, persistent stock underperformance (relative strength -20.02% over 1 year), and cyclical real estate exposure. The central tension is whether the forward earnings growth implied by the low forward P/E (15.71x) will materialize. If margins continue to improve and revenue growth sustains above 15%, the stock could re-rate higher; but any earnings miss could trigger multiple compression. Currently, the bull case has stronger evidence given the tangible margin expansion and analyst support, but the stock's technical weakness warrants caution.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue grew 18.15% YoY to $10.527B, with sequential acceleration from $8.91B in Q1 2025. This broad-based growth across Advisory Services ($2.024B) and Project Management ($1.838B) indicates market share gains and a recovery in commercial real estate activity.
- Margin Expansion Driving Earnings: Operating margin improved to 4.85% in Q1 2026 from 3.10% a year ago, while net margin rose to 3.02% from 1.83%. This operating leverage suggests cost efficiencies are taking hold as revenue scales, supporting the forward P/E of 15.71x.
- Strong Analyst Consensus and Upside: With 12 analysts, the consensus is Buy (mean 1.54) and the average target of $175.92 implies 26.1% upside from $139.46. The high target of $200 suggests potential for further gains if earnings momentum continues.
- Free Cash Flow Generation: TTM free cash flow stands at $897M, providing financial flexibility for share repurchases ($530M in Q1 2026) and debt reduction. Despite seasonal working capital outflows, the company generates solid cash from operations.
Bearish
- Elevated Trailing P/E Multiple: The trailing P/E of 41.44x is near the high end of its 5-year range (12x-60x), implying the market is pricing in optimistic future earnings. If earnings growth disappoints, multiple compression could lead to significant downside.
- Sustained Underperformance vs Market: CBRE has declined 3.55% over the past year while the S&P 500 gained 16.47%, resulting in a relative strength of -20.02%. The stock is in a downtrend, trading at 80.1% of its 52-week range, indicating persistent selling pressure.
- High Debt-to-Equity Ratio: With a debt-to-equity ratio of 1.125 and current ratio of 1.095, CBRE carries moderate financial leverage. While interest coverage of 8.66x is adequate, a prolonged downturn in real estate could strain debt servicing.
- Cyclical Exposure to Real Estate: As a commercial real estate services firm, CBRE is highly sensitive to transaction volumes and property values. A recession or sustained high interest rates could reduce leasing and capital markets activity, pressuring revenue and margins.
CBRE Technical Analysis
CBRE is in a sustained downtrend over the past year, with the stock declining 3.55% over the trailing 12 months while the S&P 500 gained 16.47%, resulting in a relative strength of -20.02%. The current price of $139.46 sits at 80.1% of its 52-week range ($121.69 low to $174.27 high), indicating the stock is closer to the lower end of its range after a significant pullback from the highs. This positioning suggests the stock may be oversold and potentially offering a value entry, but the persistent underperformance relative to the broader market warrants caution. The 1-month price change of +4.12% shows a short-term bounce, but the 3-month change of -5.95% and 6-month change of -17.59% confirm the intermediate-term downtrend remains intact. The 1-month relative strength of +3.34% versus the S&P 500 indicates recent outperformance, potentially signaling a short-term reversal attempt. However, the divergence between the positive 1-month trend and the negative 1-year trend suggests this could be a temporary mean-reversion bounce within a larger downtrend rather than a sustainable reversal. The 52-week high of $174.27 acts as key resistance, while the 52-week low of $121.69 provides support. A breakout above $174.27 would signal a potential trend reversal and renewed bullish momentum, while a breakdown below $121.69 could accelerate selling pressure. With a beta of 1.205, CBRE is 20.5% more volatile than the market, meaning it tends to amplify market moves—a factor that increases risk but also offers greater upside potential in a recovery scenario.
Beta
1.21
1.21x market volatility
Max Drawdown
-27.4%
Largest decline past year
52-Week Range
$122-$174
Price range past year
Annual Return
-5.7%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | +6.2% | +0.2% |
| 3m | +3.5% | +3.7% |
| 6m | -13.8% | +8.0% |
| 1y | -5.7% | +18.2% |
| ytd | -8.4% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
CBRE's revenue trajectory is solidly growing, with Q1 2026 revenue of $10.527 billion representing an 18.15% year-over-year increase from $8.91 billion in Q1 2025. The multi-quarter trend shows accelerating growth: Q2 2025 revenue was $9.753 billion, Q3 2025 was $10.258 billion, and Q4 2025 was $11.629 billion, indicating consistent sequential expansion. The Advisory Services segment contributed $2.024 billion and Project Management $1.838 billion in the most recent quarter, while Real Estate Investments added $199 million, showing broad-based strength across business lines. This growth trajectory supports the investment case that CBRE is gaining market share and benefiting from a recovery in commercial real estate activity. Profitability is improving, with Q1 2026 net income of $318 million and a net margin of 3.02%, up from 1.83% in Q1 2025 and 2.20% in Q2 2025. Gross margin came in at 17.59% for Q1 2026, slightly below the 18.46% in Q1 2025 but above the 15.29% in Q4 2025, suggesting some stabilization. Operating margin of 4.85% in Q1 2026 is a significant improvement from 3.10% in Q1 2025 and 3.83% in Q2 2025, indicating operating leverage is taking hold as revenue scales. The company remains profitable with positive net income across all recent quarters, and margins are trending upward, which is a positive signal for earnings quality. CBRE's balance sheet shows moderate leverage with a debt-to-equity ratio of 1.125 and a current ratio of 1.095, indicating adequate liquidity. Free cash flow (TTM) stands at $897 million, though Q1 2026 operating cash flow was negative $825 million due to working capital outflows, a seasonal pattern. Return on equity (ROE) is 13.03%, reflecting solid profitability relative to equity. The company does not pay a dividend, instead reinvesting cash into growth and share repurchases ($530 million in Q1 2026). With a debt-to-equity ratio above 1.0, CBRE carries some financial risk, but the strong free cash flow generation and interest coverage ratio of 8.66x (Q1 2026) suggest debt service is manageable.
Quarterly Revenue
$10.5B
2026-03
Revenue YoY Growth
+18.1%
YoY Comparison
Gross Margin
17.6%
Latest Quarter
Free Cash Flow
$897000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Since CBRE has positive net income ($318 million in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E stands at 41.44x, while the forward P/E is 15.71x, based on estimated EPS of $13.35. The wide gap between trailing and forward P/E implies the market expects significant earnings growth in the coming year, which is consistent with the improving margin trends and revenue acceleration. Compared to the industry average (Real Estate - Services), CBRE's trailing P/E of 41.44x appears elevated, but the forward P/E of 15.71x is more reasonable. The EV/EBITDA multiple of 21.71x is also above the sector median, reflecting a premium for CBRE's market leadership and scale. The P/S ratio of 1.18x is relatively low, suggesting the market is not fully pricing in the revenue growth potential. Historically, CBRE's trailing P/E has ranged from 12x to 60x over the past five years. The current 41.44x is near the higher end of that range, indicating the market is pricing in optimistic expectations for future earnings growth. However, the forward P/E of 15.71x is closer to the historical median, suggesting that if earnings materialize as expected, the stock could be reasonably valued. The PEG ratio of 1.82x implies the stock is trading at a slight premium to its growth rate, but not excessively so.
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~74x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CBRE's debt-to-equity ratio of 1.125 indicates moderate leverage, and while interest coverage of 8.66x is comfortable, a sharp downturn in commercial real estate could pressure cash flows. The company's free cash flow of $897M TTM is positive, but Q1 2026 operating cash flow was negative $825M due to seasonal working capital, highlighting short-term liquidity risk. Net margin of 3.02% is still low, leaving little room for error if revenue growth stalls. Additionally, the trailing P/E of 41.44x leaves the stock vulnerable to multiple compression if earnings disappoint.
Market & Competitive Risks: CBRE's beta of 1.205 makes it 20.5% more volatile than the market, amplifying downside in selloffs. The stock has underperformed the S&P 500 by 20.02% over the past year, reflecting sector rotation away from real estate. Competitive pressures from other large real estate services firms could limit market share gains. Regulatory risks include changes in property tax laws or environmental regulations affecting commercial buildings. The recent AI-driven market correction (Feb 2026) shows how macro fears can impact the stock.
Worst-Case Scenario: A severe recession causing a prolonged slump in commercial real estate transactions could drive revenue declines and margin compression. If earnings fall short of the $13.35 consensus, the forward P/E could expand, but more likely the stock would re-rate lower. The 52-week low of $121.69 represents a 12.7% downside from the current price of $139.46. In a worst case, the stock could test the low target of $138 (near current) or even fall to $121.69, implying a loss of up to 12.7%. Historically, the stock has a max drawdown of 27.37%, so a decline to $101.30 is possible in a severe bear case.
FAQ
The primary risks are: 1) Cyclical downturn in commercial real estate, which could reduce transaction volumes and pressure revenue (the stock has a beta of 1.205, amplifying market moves). 2) High trailing P/E of 41.44x leaves the stock vulnerable to multiple compression if earnings disappoint. 3) Debt-to-equity of 1.125 indicates moderate financial leverage, though interest coverage of 8.66x is adequate. 4) Competitive pressure from other large real estate services firms could limit market share gains. The most severe risk is a recession causing a 12.7% decline to the 52-week low of $121.69.
The 12-month forecast is moderately bullish. The base case (45% probability) targets $150-$175, assuming continued revenue growth and margin expansion. The bull case (30% probability) targets $175-$200, driven by a strong recovery and analyst upgrades. The bear case (25% probability) targets $122-$138, if a recession hits. The consensus analyst target is $175.92, implying 26.1% upside. The most likely scenario is the base case, where earnings meet the $13.35 consensus and the stock trades near the average target.
CBRE's valuation is mixed: the trailing P/E of 41.44x is elevated relative to the 5-year range (12x-60x) and the industry average, suggesting the market is pricing in optimistic future earnings. However, the forward P/E of 15.71x is more reasonable and below the historical median, implying the stock is fairly valued if earnings meet the $13.35 consensus. The PEG ratio of 1.82x indicates a slight premium to growth, but the P/S ratio of 1.18x is low, suggesting revenue is not fully valued. Overall, CBRE is not cheap on trailing earnings but offers value on a forward basis if growth continues.
CBRE appears to be a good buy for investors with a 12-month horizon who are bullish on a commercial real estate recovery. The stock offers 26.1% upside to the average analyst target of $175.92, supported by 18.15% revenue growth and expanding margins. However, the trailing P/E of 41.44x is high, so the investment relies on earnings growth materializing. The biggest downside risk is a recession that could push the stock to the 52-week low of $121.69, a 12.7% loss. For long-term investors, the forward P/E of 15.71x is attractive, but short-term traders should be cautious given the stock's high beta (1.205) and recent downtrend.
CBRE is better suited for long-term investment (12+ months) given its cyclical nature and growth trajectory. The stock's beta of 1.205 makes it volatile for short-term trading, and the recent downtrend (-17.59% over 6 months) adds risk. Long-term investors can benefit from the forward P/E of 15.71x and potential earnings growth, while short-term traders face uncertainty from macro factors. The company does not pay a dividend, so total return depends on price appreciation. A minimum holding period of 12 months is recommended to allow the recovery thesis to play out.